In the latest session, Entera Bio Ltd (NASDAQ: ENTX) closed at $2.29 down -9.13% from its previous closing price of $2.52. On the day, 552027 shares were traded.
Ratios:
For a deeper understanding of Entera Bio Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.32 and its Current Ratio is at 10.32. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Aegis Capital on March 22, 2021, initiated with a Buy rating and assigned the stock a target price of $12.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 12 ’24 when Taitel Haya bought 9,500 shares for $0.99 per share. The transaction valued at 9,405 led to the insider holds 35,115 shares of the business.
Taitel Haya bought 7,615 shares of ENTX for $5,864 on Jan 10 ’24. The Director now owns 25,615 shares after completing the transaction at $0.77 per share. On Dec 22 ’23, another insider, LIEBERMAN GERALD M, who serves as the Director of the company, bought 23,952 shares for $0.71 each. As a result, the insider paid 17,006 and bolstered with 226,961 shares of the company.
Stock Price History:
Over the past 52 weeks, ENTX has reached a high of $3.35, while it has fallen to a 52-week low of $0.52.
Shares Statistics:
A total of 35.48M shares are outstanding, with a floating share count of 28.70M. Insiders hold about 19.11% of the company’s shares, while institutions hold 11.45% stake in the company.
